---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-000732"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T00:33:58.707316+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences raises $900k via convertible notes with 12% interest and warrants

## Summary
- Closed $900,000 convertible note offering; directors and management purchased $200,000 of the notes.
- Notes carry 12% annual interest (20% on default), mature in 180 days; voluntary conversion at $1.29/share.
- Unconverted principal automatically converts to warrants at $0.125/share; exercise price $1.04/share.
- Warrants have 5-year term, cashless exercise option, and standard anti-dilution provisions.
- Company commits to file resale registration statement for underlying shares within 45 days after maturity.

## SEC filing metadata
- accession: 0001640334-25-000732
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425000732/0001640334-25-000732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425000732/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-000732
- JSON: https://secwatch.observer/filing/0001640334-25-000732.json
- Plain text: https://secwatch.observer/filing/0001640334-25-000732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.